Plalab Placenta Peeling (RENOCELL Co., Ltd)
Welcome to the PulseAid listing for the Plalab Placenta Peeling drug offered from RENOCELL Co., Ltd. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | RENOCELL Co., Ltd |
| NON-PROPRIETARY NAME: | JUGLANS REGIA SHELL |
| SUBSTANCE NAME: | JUGLANS REGIA SHELL |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2015-12-22 |
| END MARKETING DATE: | 0000-00-00 |
Plalab Placenta Peeling HUMAN OTC DRUG Details:
| Item Description | Plalab Placenta Peeling from RENOCELL Co., Ltd |
| LABELER NAME: | RENOCELL Co., Ltd |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.005(1/80mL) |
| START MARKETING DATE: | 2015-12-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70326-101_637c1170-1d65-4ff5-ad0e-9d108ea78b42 |
| PRODUCT NDC: | 70326-101 |
| APPLICATION NUMBER: | |
Other JUGLANS REGIA SHELL Pharmaceutical Manufacturers / Labelers:
